1. Methotrexate, Azathioprine, Cyclosporine, and Risk of Fracture

   • P. Vestergaard
   • L. Rejnmark
   • L. Mosekilde

   OriginalPaper 15 August 2006 Pages: 69 - 75

2. Proton Pump Inhibitors, Histamine H₂ Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture

   • P. Vestergaard
   • L. Rejnmark
   • L. Mosekilde

   OriginalPaper 15 August 2006 Pages: 76 - 83

3. Fracture Risk Associated with Use of Nonsteroidal Anti-Inflammatory Drugs, Acetylsalicylic Acid, and Acetaminophen and the Effects of Rheumatoid Arthritis and Osteoarthritis

   • P. Vestergaard
   • L. Rejnmark
   • L. Mosekilde

   OriginalPaper 15 August 2006 Pages: 84 - 94

4. Relationship between Vitamin D Metabolites and Bone Mineral Density in Young Males: A Cross-Sectional and Longitudinal Study

   • M. Högström
   • A. Nordström
   • P. Nordström

   OriginalPaper 15 August 2006 Pages: 95 - 101

   

5. Volumetric and Areal Bone Mineral Density Measures Are Associated with Cardiovascular Disease in Older Men and Women: The Health, Aging, and Body Composition Study

   • G. N. Farhat
   • E. S. Strotmeyer
   • J. A. Cauley

   OriginalPaper 16 August 2006 Pages: 102 - 111

6. Disruption of Four-and-a-Half LIM 2 Decreases Bone Mineral Content and Bone Mineral Density in Femur and Tibia Bones of Female Mice

   • K. E. Govoni
   • D. J. Baylink
   • S. Mohan

   OriginalPaper 15 August 2006 Pages: 112 - 117

   

7. Impaired Cortical Bone Acquisition and Osteoblast Differentiation in Mice with Osteoblast-Targeted Disruption of Glucocorticoid Signaling

   • L. B. Sher
   • J. R. Harrison
   • B. E. Kream

   OriginalPaper 17 August 2006 Pages: 118 - 125